Jan Rekowski

15PUBLICATIONS
142CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Stochastic analysis and modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 08, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer.

Juan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo

|Jun 27, 2025
Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial.

Susana Banerjee, Matthew G Krebs, Alastair Greystoke

|Jan 09, 2025
NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth.

Jonathan Welti, Denisa Bogdan, Ines Figueiredo

|Feb 27, 2024
Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate Cancer.

Antje Neeb, Ines Figueiredo, Denisa Bogdan

|Oct 16, 2023
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.

Christina Guo, Adam Sharp, Bora Gurel

|Nov 10, 2021
HER3 Is an Actionable Target in Advanced Prostate Cancer.

Veronica Gil, Susana Miranda, Ruth Riisnaes

Pageof 3

Frequent Collaborators

9 joint publications

Johann S de Bono

7 joint publications

Suzanne Carreira

7 joint publications

Susana Miranda

6 joint publications

Bora Gurel